Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Stevens

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 27, 2019
Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta-analysisDaniel Horner, John W Stevens, Abdullah Pandor, et al.
Pharmaceutical Statistics|April 3, 2009
The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulationRichard M Nixon, Anthony O'Hagan, Jeremy Oakley, et al.
Pharmacoeconomics|August 4, 2017
Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHazel Squires, Abdullah Pandor, Praveen Thokala, et al.
Pharmacoeconomics|March 30, 2018
Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachid Rafia, Abdullah Pandor, Sarah Davis, et al.
Emergency Medicine Journal : EMJ|May 18, 2012
Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysisChristopher Carroll, Mohamad Al Khalaf, John W Stevens, et al.
British Journal of Haematology|January 31, 2019
Decision-analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injurySarah Davis, Steve Goodacre, Abdullah Pandor, et al.
Health Technology Assessment (Winchester, England)|May 17, 2014
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluationJoanna Leaviss, William Sullivan, Shijie Ren, et al.
Pharmacoeconomics|May 28, 2017
Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Rachel Archer, et al.
Diabetes Research and Clinical Practice|February 2, 2015
Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventionsJohn W Stevens, Kamlesh Khunti, Rebecca Harvey, et al.
Epilepsy & Behavior : E&B|March 1, 2003
Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential AnalysisMartin J. Brodie, Stephen J. Wroe, Andrew D. P. Dean, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|October 27, 2019
Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta-analysisDaniel Horner, John W Stevens, Abdullah Pandor, et al.
Pharmaceutical Statistics|April 3, 2009
The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulationRichard M Nixon, Anthony O'Hagan, Jeremy Oakley, et al.
Pharmacoeconomics|August 4, 2017
Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHazel Squires, Abdullah Pandor, Praveen Thokala, et al.
Pharmacoeconomics|March 30, 2018
Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachid Rafia, Abdullah Pandor, Sarah Davis, et al.
Emergency Medicine Journal : EMJ|May 18, 2012
Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysisChristopher Carroll, Mohamad Al Khalaf, John W Stevens, et al.
British Journal of Haematology|January 31, 2019
Decision-analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injurySarah Davis, Steve Goodacre, Abdullah Pandor, et al.
Health Technology Assessment (Winchester, England)|May 17, 2014
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluationJoanna Leaviss, William Sullivan, Shijie Ren, et al.
Pharmacoeconomics|May 28, 2017
Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Rachel Archer, et al.
Diabetes Research and Clinical Practice|February 2, 2015
Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventionsJohn W Stevens, Kamlesh Khunti, Rebecca Harvey, et al.
Epilepsy & Behavior : E&B|March 1, 2003
Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential AnalysisMartin J. Brodie, Stephen J. Wroe, Andrew D. P. Dean, et al.
Pageof 5